Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Farmers Insurance
Federal Trade Commission
Boehringer Ingelheim

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,241,907

« Back to Dashboard

Which drugs does patent 7,241,907 protect, and when does it expire?

Patent 7,241,907 protects JEVTANA KIT and is included in one NDA.

Protection for JEVTANA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty patent family members in thirty-five countries.

Summary for Patent: 7,241,907

Title:Acetone solvate of dimethoxy docetaxel and its process of preparation
Abstract:This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1-hydroxy-7.beta.,10.beta.- -dimethoxy-9-oxotax-11-en-13.alpha.-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
Inventor(s): Didier; Eric (Paris, FR), Perrin; Marc-Antoine (Jouy en Josas, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:10/944,254
Patent Claim Types:
see list of patent claims
Compound; Use; Process; Use; Compound; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis UsJEVTANA KITcabazitaxelSOLUTION;IV (INFUSION)201023-001Jun 17, 2010RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,241,907

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France03 11016Sep 19, 2003

International Patent Family for Patent: 7,241,907

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina045667► Subscribe
Australia2004274212► Subscribe
BrazilPI0414492► Subscribe
Canada2539309► Subscribe
China100429207► Subscribe
China1849311► Subscribe
Costa Rica8292► Subscribe
Cyprus1114575► Subscribe
Denmark1667986► Subscribe
European Patent Office1667986► SubscribeC01667986/01Switzerland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: